Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 23 4 2019
pubmed: 23 4 2019
medline: 9 1 2020
Statut: ppublish

Résumé

Background and Purpose- We aimed to determine incidences and predictors of major vascular events in intracerebral hemorrhage (ICH) survivors. Methods- We did a prospective observational cohort study in patients with spontaneous ICH from the Prognosis of Intracerebral Hemorrhage cohort in Lille, France. We studied incidences and predictors of long-term vascular events (cerebral and extracerebral, ischemic and hemorrhagic) in patients alive at 30 days with a prespecified subgroup analysis according to ICH location. We performed multivariable analyses (competing risk analyses, with death during follow-up as a competing event). Results- From the 560 patients with spontaneous ICH enrolled between November 2004 and March 2009, we included 310 patients (median age, 70 years). Eighty-two patients presented at least 1 major vascular event leading to an incidence rate of 20.0% (95% CI, 15.7-24.7) at 5 years after ICH. In the overall cohort, ischemic events were more frequent than hemorrhagic events. However, the incidence strikingly differed according to ICH location: deep ICH was associated with future ischemic events (subhazard ratio, 1.85; 95% CI, 1.01-3.40), whereas lobar ICH with hemorrhagic events (subhazard ratio, 2.38; 95% CI, 1.17-4.86). In deep ICH, the incidence of ischemic events at 5 years was 6× higher than the incidence of hemorrhagic events. Conclusions- ICH survivors are at high risk of both cerebral and extracerebral vascular events. The ischemic or hemorrhagic risk profile varies according to the index ICH location with a stronger ischemic risk in deep ICH. Secondary prevention, tailored on ICH location, should target not only cerebral recurrences but also extracerebral vascular events.

Identifiants

pubmed: 31009357
doi: 10.1161/STROKEAHA.118.024449
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1100-1107

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Barbara Casolla (B)

From the Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, Lille, France (B.C., S.M., H.H., D.L., C.C.).

Solène Moulin (S)

From the Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, Lille, France (B.C., S.M., H.H., D.L., C.C.).

Maéva Kyheng (M)

Univ. Lille, CHU Lille, EA 2694 Santé Publique: épidémiologie et Qualité des Soins, Lille, France (M.K., J.L.).

Hilde Hénon (H)

From the Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, Lille, France (B.C., S.M., H.H., D.L., C.C.).

Julien Labreuche (J)

Univ. Lille, CHU Lille, EA 2694 Santé Publique: épidémiologie et Qualité des Soins, Lille, France (M.K., J.L.).

Didier Leys (D)

From the Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, Lille, France (B.C., S.M., H.H., D.L., C.C.).

Christophe Bauters (C)

Univ. Lille, Inserm U1167, Institut Pasteur et CHU Lille, Lille, France (C.B.).

Charlotte Cordonnier (C)

From the Univ. Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, CHU Lille, Department of Neurology, Lille, France (B.C., S.M., H.H., D.L., C.C.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH